Filament Health FLHLF Stock
Filament Health Price Chart
Filament Health FLHLF Financial and Trading Overview
| Filament Health stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0.01 USD x 0 |
| Ask | 0.02 USD x 1000000 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 0.0001 - 0.02 USD |
| Volume | 30K USD |
| Avg. Volume | 178 USD |
| Market Cap | 26.18K USD |
| Beta (5Y Monthly) | 0.724 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
FLHLF Valuation Measures
| Enterprise Value | 202.36K USD |
| Trailing P/E | N/A |
| Forward P/E | -0.0016666667 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.0570922 |
| Price/Book (mrq) | 0.068498775 |
| Enterprise Value/Revenue | 0.441 |
| Enterprise Value/EBITDA | -0.068 |
Trading Information
Filament Health Stock Price History
| Beta (5Y Monthly) | 0.724 |
| 52-Week Change | -99.43% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.02 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0089555 USD |
FLHLF Share Statistics
| Avg. Volume (3 month) | 178 USD |
| Avg. Daily Volume (10-Days) | 1K USD |
| Shares Outstanding | 261.79M |
| Float | 111.1M |
| Short Ratio | N/A |
| % Held by Insiders | 49.39% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -5153.32% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -54.69% |
| Return on Equity (ttm) | -272.16% |
Income Statement
| Revenue (ttm) | 458.54K USD |
| Revenue Per Share (ttm) | 0.002 USD |
| Quarterly Revenue Growth (yoy) | -50.00000000000000000000000000000000% |
| Gross Profit (ttm) | 458.54K USD |
| EBITDA | -2972605 USD |
| Net Income Avi to Common (ttm) | -4105729 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 337.08K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 513.27K USD |
| Total Debt/Equity (mrq) | 97.71 USD |
| Current Ratio (mrq) | 0.303 |
| Book Value Per Share (mrq) | 0.00145988 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1341995 USD |
| Levered Free Cash Flow (ttm) | -130500 USD |
Profile of Filament Health
| Country | United States |
| State | BC |
| City | Burnaby |
| Address | 4475 Wayburne Drive |
| ZIP | V5G 4X4 |
| Phone | N/A |
| Website | https://filament.health |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. The company's leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. It also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, the company provides in-house human clinical trials, as well as license technology to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
Q&A For Filament Health Stock
What is a current FLHLF stock price?
Filament Health FLHLF stock price today per share is 0.0001 USD.
How to purchase Filament Health stock?
You can buy FLHLF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Filament Health?
The stock symbol or ticker of Filament Health is FLHLF.
Which industry does the Filament Health company belong to?
The Filament Health industry is Drug Manufacturers - Specialty & Generic.
How many shares does Filament Health have in circulation?
The max supply of Filament Health shares is 261.79M.
What is Filament Health Price to Earnings Ratio (PE Ratio)?
Filament Health PE Ratio is now.
What was Filament Health earnings per share over the trailing 12 months (TTM)?
Filament Health EPS is -0.01 USD over the trailing 12 months.
Which sector does the Filament Health company belong to?
The Filament Health sector is Healthcare.